The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.
Open accessAbstract
We investigated the role of the costimulatory molecules, CD40 and its ligand CD40L, in the pathogenesis of human SLE.In comparison to normal subjects or patients in remission, PBMC from active lupus patients had a 21-fold increase in the frequency of CD40L-expressing, CD4 ϩ T cells.However, the expression of CD40L induced in either lupus or normal T cells by mitogenic stimulation could be downregulated equally well by CD40 molecules on autologous B cells.Active lupus patients also had a 22-fold increase in percentage of CD8 ϩ T cells expressing CD40L, consistent with their unusual helper activity in SLE.Surprisingly, patients with active lupus had a 20.5-fold increase in B cells that spontaneously expressed high levels of CD40L, as strongly as their T cells.Although lupus patients in remission had low levels of CD40L ϩ cells in the range of normal subjects, mitogen-induced upregulation of CD40L expression in their T and B cells was markedly greater than normal, suggesting an intrinsic defect.A mAb to CD40L blocked significantly the ability of lymphocytes from lupus patients with active and established disease to produce the pathogenic variety of antinuclear autoantibodies in vitro, bolstering the possibility of anti-CD40L immunotherapy for lupus.Future studies on the hyperexpression of CD40L could elucidate a regulatory defect in the pathogenic T and B cells of lupus.( J. Clin.Invest.1996.97:2063-2073.)Key words: system lupus erythematosus • anti-DNA autoantibodies • autoimmune disease • CD40 ligand expression • immunotherapy MethodsPatients and healthy donors.Eight patients with active lupus (seven females and one male; aged 18-50 yr), seven patients in long-term remission (all females; aged 21-51 yr) and six normal (healthy) subjects
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gyllensten, U. B., & Erlich, H. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7652 · Cited by 1,560
The CD40 Antigen and Its Ligand
Banchereau, J., Bazan, F., Blanchard, D., Brière, F., Galizzi, J., van Kooten, C., Liu, Y. J., Rousset, F., & Saeland, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.881 · Cited by 1,263
Mechanism of antigen-driven selection in germinal centres
Liu, Y.-J., Joshua, D. E., Williams, G. T., Smith, C. A., Gordon, J., & MacLennan, I. C. M. (1989) · Nature · doi:10.1038/342929a0 · Cited by 1,081
Noelle, R. J., Roy, M., Shepherd, D. M., Stamenkovic, I., Ledbetter, J. A., & Aruffo, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6550 · Cited by 804
Liang, M. H., Socher, S. A., Larson, M. G., & Schur, P. H. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320909 · Cited by 789
Treatment of Murine Lupus with CTLA4Ig
Finck, B. K., Linsley, P. S., & Wofsy, D. (1994) · Science · doi:10.1126/science.7520604 · Cited by 668
How B and T cells talk to each other
Clark, E. A., & Ledbetter, J. A. (1994) · Nature · doi:10.1038/367425a0 · Cited by 641
Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.
Mohan, C., Adams, S., Stanik, V, & Datta, S. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.5.1367 · Cited by 627
Self-citationRanheim, E. A., & Kipps, T. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.925 · Cited by 580
Foy, T. M., Laman, J. D., Ledbetter, J. A., Aruffo, A., Claassen, E., & Noelle, R. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.157 · Cited by 440
Shivakumar, S., Tsokos, G. C., & Datta, S. K. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.1.103 · Cited by 402
Self-citationRecombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion.
Spriggs, M. K., Armitage, R. J., Strockbine, L. D., Clifford, K. N., Macduff, B. M., Sato, T., Maliszewski, C. R., & Fanslow, W. C. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.6.1543 · Cited by 388
B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40
Tsubata, T., Wu, J., & Honjo, T. (1993) · Nature · doi:10.1038/364645a0 · Cited by 381
The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells.
Roy, M., Waldschmidt, T., Aruffo, A., Ledbetter, J. A., & Noelle, R. J. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2497 · Cited by 366
Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.
Mohan, C., Shi, Y., Laman, J. D., & Datta, S. K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1470 · Cited by 364
Self-citationJames, J. A., Gross, T., Scofield, R. H., & Harley, J. B. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.453 · Cited by 339
Systemic autoimmune disease arises from polyclonal B cell activation.
Klinman, D. M., & Steinberg, A. D. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.6.1755 · Cited by 308
Burlingame, R. W., Boey, M. L., Starkebaum, G., & Rubin, R. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117305 · Cited by 300
Schattner, E. J., Elkon, K. B., Yoo, D. H., Tumang, J., Krammer, P. H., Crow, M. K., & Friedman, S. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1557 · Cited by 278
Gleichmann, E., Elven, E. H. V., & van der Veen, J. P. W. (1982) · European Journal of Immunology · doi:10.1002/eji.1830120210 · Cited by 269
Maggi, E., Giudizi, M. G., Biagiotti, R., Annunziato, F., Manetti, R., Piccinni, M. P., Parronchi, P., Sampognaro, S., Giannarini, L., Zuccati, G., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.489 · Cited by 267
The Role Of Somatic Mutation In The Pathogenic Anti-DNA Response
Diamond, B. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.731 · Cited by 247
Ren, C. L., Morio, T., Fu, S. M., & Geha, R. S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.673 · Cited by 230
Burlingame, R. W., Rubin, R. L., Balderas, R. S., & Theofilopoulos, A. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116378 · Cited by 230
B cells process and present lupus autoantigens that initiate autoimmune T cell responses.
Mamula, M. J., Fatenejad, S., & Craft, J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.3.1453 · Cited by 229
Datta, S. K., Patel, H., & Berry, D. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.5.1252 · Cited by 227
Self-citationYellin, M. J., Sippel, K., Inghirami, G., Covey, L. R., Lee, J. J., Sinning, J., Clark, E. A., Chess, L., & Lederman, S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.2.598 · Cited by 204
The CD40 ligand expressed by human B cells costimulates B cell responses.
Grammer, A. C., Bergman, M. C., Miura, Y., Fujita, K., Davis, L. S., & Lipsky, P. E. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.4996 · Cited by 195
Ware, C. F., Crowe, P. D., Vanarsdale, T. L., Andrews, J. L., Grayson, M. H., Jerzy, R., Smith, C. A., & Goodwin, R. G. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.12.4229 · Cited by 174
Rothfield, N. F., & Stollar, B. D. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105669 · Cited by 173
Vassilopoulos, D., Kovacs, B., & Tsokos, G. C. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2269 · Cited by 162
van Kooten, C., Gaillard, C., Galizzi, J., Hermann, P., Fossiez, F., Banchereau, J., & Blanchard, D. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240402 · Cited by 162
Desai-Mehta, A., Mao, C., Rajagopalan, S., Robinson, T., & Datta, S. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117695 · Cited by 160
Self-citationDiminished expression of CD40 ligand by activated neonatal T cells.
Nonoyama, S., Penix, L. A., Edwards, C. P., Lewis, D. B., Ito, S., Aruffo, A. A., Wilson, C. B., & Ochs, H. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117677 · Cited by 155
Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice.
Desai, D. D., Krishnan, M. R., Swindle, J., & Marion, T. N. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1614 · Cited by 152
Regulation of expression of the ligand for CD40 on T helper lymphocytes.
Castle, B. E., Kishimoto, K., Stearns, C. D., Brown, M. L., & Kehry, M. R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.4.1777 · Cited by 152
Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction.
Klaus, S. J., Pinchuk, L. M., Ochs, H. D., Law, C., Fanslow, W. C., Armitage, R. J., & Clark, E. A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.12.5643 · Cited by 150
In the absence of a CD40 signal, B cells are tolerogenic
Suhlmann, J. E., Foy, T. M., Aruffo, A. A., Crassi, K. M., Ledbetter, J. A., Green, W. R., Xu, J., Shultz, L. D., Roopeslan, D., Flavell, R. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90009-8 · Cited by 146
Ando, D. G., Sercarz, E. E., & Hahn, B. H. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.10.3185 · Cited by 145
Induction of B cell costimulatory function by recombinant murine CD40 ligand
Kennedy, M. K., Mohler, K. M., Shanebeck, K. D., Baum, P. R., Picha, K. S., Otten-Evans, C., Janeway, C. A., & Grabstein, K. H. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240118 · Cited by 142
Singh, R. R., Kumar, V., Ebling, F. M., Southwood, S., Sette, A., Sercarz, E. E., & Hahn, B. H. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.6.2017 · Cited by 141
Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells
Wang, Z., Karras, J. G., Howard, R. G., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3722 · Cited by 126
Faris, M., Gaskin, F., Parsons, J. T., & Fu, S. M. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.6.1923 · Cited by 125
Facchetti, F., Appiani, C., Salvi, L., Levy, J., & Notarangelo, L. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.12.6624 · Cited by 123
Lederman, S. M., Yellin, M. J., Cleary, A. M., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.5.2163 · Cited by 121
Reininger, L., Radaszkiewicz, T., Kosco, M. H., et al. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.5.1343 · Cited by 117
Moens, U. L., Seternes, O. M., Hey, A., Silsand, Y., Traavik, T., Johansen, B., & Rekvig, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12393 · Cited by 107
Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes.
Kammer, G. M., Khan, I., & Malemud, C. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117340 · Cited by 87
Suzuki, N., Harada, T., Mizushima, Y., & Sakane, T. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.2.1128 · Cited by 71
Kuwana, M., Medsger, T. A., & Wright, T. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2703 · Cited by 71
Sabbaga, J., PANKEWYCZ, O. G., Lufft, V., Schwartz, R. S., & Madaio, M. P. (1990) · Journal of Autoimmunity · doi:10.1016/0896-8411(90)90142-f · Cited by 68
Datta, S., Owen, F. L., Womack, J. E., et al. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.4.1539 · Cited by 67
Self-citationMerino, R., Iwamoto, M., Fossati, L., & Izui, S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.11.6509 · Cited by 59
Crow, M. K., DelGiudice-Asch, G., Zehetbauer, J. B., Lawson, J. L., Brot, N., Weissbach, H., & Elkon, K. B. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117328 · Cited by 49
Sullivan, K. E. (1996) · PEDIATRICS · doi:10.1542/peds.98.2.350 · Cited by 34
Cationic and high affinity serum IgG anti-dsDNA antibodies in active lupus nephritis
Suenaga, R., & Abdou, N. I. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb08211.x · Cited by 31
Structure of the murine CD40 ligand gene
Tsitsikov, E. N., Ramesh, N., & Geha, R. S. (1994) · Molecular Immunology · doi:10.1016/0161-5890(94)90009-4 · Cited by 28
Cited by
van Kooten, C., & Banchereau, J. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.1.2 · Cited by 1,404
Immune Regulatory Function of B Cells
Mauri, C., & Bosma, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074934 · Cited by 1,249
The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review
Schönbeck*RID="*"ID="*" Correspondi, U., & Libby, P. (2001) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000776 · Cited by 737
Boumpas, D. T., Furie, R., Manzi, S., Illei, G. G., Wallace, D. J., Balow, J. E., Vaishnaw, A., & on behalf of the BG9588 Lupus Nephritis Trial Group (2003) · Arthritis & Rheumatism · doi:10.1002/art.10856 · Cited by 618
Seki, T., Yuasa, S., Oda, M., Egashira, T., Yae, K., Kusumoto, D., Nakata, H., Tohyama, S., Hashimoto, H., Kodaira, M., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.003 · Cited by 584
Metadata
- Authors
- Desai-Mehta, A., Lu, L., Ramsey-Goldman, R., & Datta, S. K.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-05-01
- Volume
- 97
- Issue
- 9
- Pages
- 2063-2073
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2063661003
- Cited by
- 517
- References
- 57
- FWCI
- 18.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.